The use of statins in conjunction with protease inhibitors and in renal insufficiency.
Mikhail
Nasser
N
Cope
Dennis
D
D019540:Area Under Curve; D003327:Coronary Disease / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D006949:Hyperlipidemias / Q000188:drug therapy; D015228:Hypertriglyceridemia / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D011480:Protease Inhibitors / Q000009:adverse effects*; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011480:Protease Inhibitors